Quick Answer
MANGOCEUTICALS, INC. reported Stockholders Equity of $13.95 million for the year ending 2024.
- MANGOCEUTICALS, INC. showed an increase of +1,700.1% in Stockholders Equity from 2023 to 2024.
- This data is from MANGOCEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 20, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: -$35.4 thousand | Q2 2022: -$119.0 thousand | Q3 2022: $823.6 thousand | Q1 2023: $3.82 million | Q2 2023: $3.00 million | Q3 2023: $1.35 million | Q1 2024: -$958.4 thousand | Q2 2024: $13.83 million | Q3 2024: $13.39 million | Q4 2024: $13.95 million | Q1 2025: $20.25 million | Q2 2025: $19.24 million | Q3 2025: $15.73 million.
- Over the full 4 years of available data (2021 to 2024), MANGOCEUTICALS, INC.'s Stockholders Equity has grown by 83,509.9%.
- Historical annual values: Fiscal year 2024: $13.95 million | Fiscal year 2023: $774.8 thousand | Fiscal year 2022: $614.0 thousand | Fiscal year 2021: -$16.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: